The study subjects included 100 patients* with confirmed type 2 diabetes. These patients are recruited by the Association and Hefei Changgeng Hospital. The joining are voluntary and they are required to prior consult their personal doctors for the suitability to participate the study. They have to sign a “Consent Form” ensuring that they understand the entire clinical trial process, the purposes and the data collection, and the right to cancel their participation anytime at their own wish. The criteria for screening participants are as follows:
Type of Disease： Type 2 Diabetes
Age Range ： 18-65 Years
Patient Gender： Not Limited
HbA1c Value： >8.5%
Other Conditions：No other serious illness except diabetes and related sickness, such as high blood pressure, high cholesterol and high triglycerides.
Each participant will go through a detailed physical examination and will be assigned a computerized patient ID number before the commencement of clinical trial. All indexes are recorded by this number and will be used as the basis for this clinical trial. All testing during the clinical trial will be performed by responsible nursing staff. On the 20th, 70th and 90th days, the patients will be required to go to the designated laboratory to verify their glycosylated hemoglobin and other indexes. Personal background, family history and all other information are processed anonymously.
*59 patients with type 2 diabetes from China and Hong Kong were eventually recruited to participate the study. Figure (A) below shows the number and age distribution of patients taking part in clinical trial research project :
國際警察協會(香港分會)榮譽會長